Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Biogen Says FDA Issued A Complete Response Letter For NDA For High Dose Regimen Of Nusinersen, Requesting Update To Technical Information Be Included In Chemistry Manufacturing And Controls Module Of The sNDA

Author: Benzinga Newsdesk | September 23, 2025 04:31pm

Posted In: BIIB